We are a multidisciplinary laboratory that combines advanced neuroimaging and therapeutic ultrasound to develop diagnostic biomarkers and pioneering non-invasive treatments for neurodegenerative disease.
Bringing together engineers, physicists and computer scientists, we develop cutting-edge technological solutions to advance neuroengineering and applied neuroscience.
Treating deep brain structures without a single incision.
AI and large-scale data power our biomarkers and predictive models.
A direct link between scientific discovery and clinical reality.
Our work spans the full arc of non-invasive neurotechnology.
Multimodal PET/MRI biomarkers for Parkinson's disease.
02Incision-free lesioning of deep brain targets.
03Ultrasound-enabled drug and gene delivery across the BBB.
04Transcranial stimulation to map circuits and find targets.
A dose–response framework for online monitoring of BBB opening by focused ultrasound.
Refining focused-ultrasound techniques to precisely control BBB opening.
The detailed timeline and milestones for our BBB-opening project.
Read more →
A week in the French Alps with leaders in therapeutic ultrasound.
Read more →
A successful doctoral defence on nigrostriatal degeneration.
Read more →We partner with academia, clinicians and industry pioneers.
Start a conversation →